Subarachnoid Block With Ultrasound-Guided Transversalis Fascia Plane Block for Cesarean Section

Ataturk University

Status and phase: Completed; Phase 4

Conditions: Caesarean Section; Pain, Acute

Treatments: Drug: Bupivacaine Hcl 0.25% Inj; Drug: saline 0.9%

Study type: Interventional

Funder types: Other

Identifiers

NCT04172727

AUTF ANESTHESIAOBSTETRIC

Details and patient eligibility

About

Postoperative pain management is critical for the fulfillment of the maternal duties. The transversalis fascia plane (TFP) block provides adequate postoperative analgesia in the T12 and L1 dermatomes. The aim of this study was to investigate the effect of the TFP block on postoperative opioid consumption and pain scores in patients undergoing cesarean section (CS) under spinal anesthesia.

Enrollment: 60 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• aged between 18 and 45
• American Society of Anesthesiologists (ASA) physical score I or II

Exclusion criteria

• Patients who received general anesthesia
• hypersensitivity to the agents to be used
• body mass index (BMI) greater than 35 kg/m2
• coagulopathy
• local infections
• opioid addiction
• pregnancy-related hypertension or diabetes mellitus

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

60 participants in 2 patient groups, including a placebo group

ultrasound guided transversalis fascia plane block

Active Comparator group

Description:

20 mL of 0.25% bupivacaine

Treatment:

Drug: Bupivacaine Hcl 0.25% Inj

ultrasound guided sham block

Placebo Comparator group

Description:

20 mL of saline

Treatment:

Drug: saline 0.9%